7,961 research outputs found

    Big Data Transforms Discovery-Utilization Therapeutics Continuum.

    Get PDF
    Enabling omic technologies adopt a holistic view to produce unprecedented insights into the molecular underpinnings of health and disease, in part, by generating massive high-dimensional biological data. Leveraging these systems-level insights as an engine driving the healthcare evolution is maximized through integration with medical, demographic, and environmental datasets from individuals to populations. Big data analytics has accordingly emerged to add value to the technical aspects of storage, transfer, and analysis required for merging vast arrays of omic-, clinical-, and eco-datasets. In turn, this new field at the interface of biology, medicine, and information science is systematically transforming modern therapeutics across discovery, development, regulation, and utilization

    Improving Patient Care with Machine Learning: A Game-Changer for Healthcare

    Get PDF
    Machine learning has revolutionized the field of healthcare by offering tremendous potential to improve patient care across various domains. This research study aimed to explore the impact of machine learning in healthcare and identify key findings in several areas.Machine learning algorithms demonstrated the ability to detect diseases at an early stage and facilitate accurate diagnoses by analyzing extensive medical data, including patient records, lab results, imaging scans, and genetic information. This capability holds the potential to improve patient outcomes and increase survival rates.The study highlighted that machine learning can generate personalized treatment plans by analyzing individual patient data, considering factors such as medical history, genetic information, and treatment outcomes. This personalized approach enhances treatment effectiveness, reduces adverse events, and contributes to improved patient outcomes.Predictive analytics utilizing machine learning techniques showed promise in patient monitoring by leveraging real-time data such as vital signs, physiological information, and electronic health records. By providing early warnings, healthcare providers can proactively intervene, preventing adverse events and enhancing patient safety.Machine learning played a significant role in precision medicine and drug discovery. By analyzing vast biomedical datasets, including genomics, proteomics, and clinical trial information, machine learning algorithms identified novel drug targets, predicted drug efficacy and toxicity, and optimized treatment regimens. This accelerated drug discovery process holds the potential to provide more effective and personalized treatment options.The study also emphasized the value of machine learning in pharmacovigilance and adverse event detection. By analyzing the FDA Adverse Event Reporting System (FAERS) big data, machine learning algorithms uncovered hidden associations between drugs, medical products, and adverse events, aiding in early detection and monitoring of drug-related safety issues. This finding contributes to improved patient safety and reduced occurrences of adverse events.The research demonstrated the remarkable potential of machine learning in medical imaging analysis. Deep learning algorithms trained on large datasets were able to detect abnormalities in various medical images, facilitating faster and more accurate diagnoses. This technology reduces human error and ultimately leads to improved patient outcomes.While machine learning offers immense benefits, ethical considerations such as patient privacy, algorithm bias, and transparency must be addressed for responsible implementation. Healthcare professionals should remain central to decision-making processes, utilizing machine learning as a tool to enhance their expertise rather than replace it. This study showcases the transformative potential of machine learning in revolutionizing healthcare and improving patient care

    Leveraging FAERS and Big Data Analytics with Machine Learning for Advanced Healthcare Solutions

    Get PDF
    This research study explores the potential of leveraging the FDA Adverse Event Reporting System (FAERS), combined with big data analytics and machine learning techniques, to enhance healthcare solutions. FAERS serves as a comprehensive database maintained by the U.S. Food and Drug Administration (FDA), encompassing reports of adverse events, medication errors, and product quality issues associated with diverse drugs and therapeutic interventions.By harnessing the power of big data analytics applied to the vast information within FAERS, healthcare professionals and researchers gain valuable insights into drug safety, discover potential adverse reactions, and uncover patterns that may not have been discernible through traditional methods. Particularly, machine learning plays a pivotal role in processing and analyzing this extensive dataset, enabling the extraction of meaningful patterns and prediction of adverse events.The findings of this study demonstrate various ways in which FAERS, big data analytics, and machine learning can be leveraged to provide advanced healthcare solutions. Machine learning algorithms trained on FAERS data can effectively identify early signals of adverse events associated with specific drugs or treatments, allowing for prompt detection and appropriate actions.Big data analytics applied to FAERS data facilitate pharmacovigilance and drug safety monitoring. Machine learning models automatically classify and analyze adverse event reports, efficiently flagging potential safety concerns and identifying emerging trends.The integration of FAERS data with big data analytics and machine learning enables signal detection and causality assessment. This approach aids in the identification of signals that suggest a causal relationship between drugs and adverse events, thereby enhancing the assessment of drug safety.By analyzing FAERS data in conjunction with patient-specific information, machine learning models can assist in identifying patient subgroups that are more susceptible to adverse events. This information is instrumental in personalizing treatment plans and optimizing medication choices, ultimately leading to improved patient outcomes.The combination of FAERS data with other biomedical information offers insights into potential new uses or indications for existing drugs. Machine learning algorithms analyze the integrated data, identifying patterns and making predictions about the efficacy and safety of repurposing existing drugs for new applications.The implementation of FAERS, big data analytics, and machine learning in advanced healthcare solutions necessitates meticulous consideration of data privacy, security, and ethical implications. Safeguarding patient privacy and ensuring responsible data use through anonymization techniques and appropriate data governance are paramount.The integration of FAERS, big data analytics, and machine learning holds immense potential in advancing healthcare solutions, enhancing patient safety, and optimizing medical interventions. The findings of this study demonstrate the multifaceted benefits that can be derived from leveraging these technologies, paving the way for a more efficient and effective healthcare ecosystem

    Knowledge-based best of breed approach for automated detection of clinical events based on German free text digital hospital discharge letters

    Get PDF
    OBJECTIVES: The secondary use of medical data contained in electronic medical records, such as hospital discharge letters, is a valuable resource for the improvement of clinical care (e.g. in terms of medication safety) or for research purposes. However, the automated processing and analysis of medical free text still poses a huge challenge to available natural language processing (NLP) systems. The aim of this study was to implement a knowledge-based best of breed approach, combining a terminology server with integrated ontology, a NLP pipeline and a rules engine. METHODS: We tested the performance of this approach in a use case. The clinical event of interest was the particular drug-disease interaction "proton-pump inhibitor [PPI] use and osteoporosis". Cases were to be identified based on free text digital discharge letters as source of information. Automated detection was validated against a gold standard. RESULTS: Precision of recognition of osteoporosis was 94.19%, and recall was 97.45%. PPIs were detected with 100% precision and 97.97% recall. The F-score for the detection of the given drug-disease-interaction was 96,13%. CONCLUSION: We could show that our approach of combining a NLP pipeline, a terminology server, and a rules engine for the purpose of automated detection of clinical events such as drug-disease interactions from free text digital hospital discharge letters was effective. There is huge potential for the implementation in clinical and research contexts, as this approach enables analyses of very high numbers of medical free text documents within a short time period

    Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research.

    Get PDF
    BackgroundJuvenile idiopathic arthritis is the most common rheumatic disease in children. Chronic uveitis is a common and serious comorbid condition of juvenile idiopathic arthritis, with insidious presentation and potential to cause blindness. Knowledge of clinical associations will improve risk stratification. Based on clinical observation, we hypothesized that allergic conditions are associated with chronic uveitis in juvenile idiopathic arthritis patients.MethodsThis study is a retrospective cohort study using Stanford's clinical data warehouse containing data from Lucile Packard Children's Hospital from 2000-2011 to analyze patient characteristics associated with chronic uveitis in a large juvenile idiopathic arthritis cohort. Clinical notes in patients under 16 years of age were processed via a validated text analytics pipeline. Bivariate-associated variables were used in a multivariate logistic regression adjusted for age, gender, and race. Previously reported associations were evaluated to validate our methods. The main outcome measure was presence of terms indicating allergy or allergy medications use overrepresented in juvenile idiopathic arthritis patients with chronic uveitis. Residual text features were then used in unsupervised hierarchical clustering to compare clinical text similarity between patients with and without uveitis.ResultsPreviously reported associations with uveitis in juvenile idiopathic arthritis patients (earlier age at arthritis diagnosis, oligoarticular-onset disease, antinuclear antibody status, history of psoriasis) were reproduced in our study. Use of allergy medications and terms describing allergic conditions were independently associated with chronic uveitis. The association with allergy drugs when adjusted for known associations remained significant (OR 2.54, 95% CI 1.22-5.4).ConclusionsThis study shows the potential of using a validated text analytics pipeline on clinical data warehouses to examine practice-based evidence for evaluating hypotheses formed during patient care. Our study reproduces four known associations with uveitis development in juvenile idiopathic arthritis patients, and reports a new association between allergic conditions and chronic uveitis in juvenile idiopathic arthritis patients
    • …
    corecore